Sarah Cannon Research Institute
Harbinger Health Joins Emerging Multi-Cancer Screening Arena With Tech Focused On Oncogenesis
Premium
The company recently signed a partnership with Sarah Cannon to conduct a 10,000-patient clinical study to further validate its experimental assay.
Sarah Cannon Cancer Institute Acquires Genospace
The cloud-based personalized medicine software company will stay in Cambridge, Massachusetts and will become a wholly-owned subsidiary of the institute.
Foundation Medicine, Sarah Cannon Partner on Genomic Profiling for Cancer Clinical Trials
Under the agreement, researchers can use Foundation Medicine's assays to select patients eligible for Sarah Cannon Research Institute's clinical studies.
Drugmakers Increasingly Using Basket Trials to Gain Precision Medicine Insights, ASCO Studies Show
Premium
Researchers presented data suggesting that pharma companies are using basket studies to identify molecularly defined patient subsets who might benefit from their drugs.
Biocept, Sarah Cannon Partner for Breast Cancer Screening
The partners will explore the use of Biocept's liquid biopsy technology to identify and detect biomarkers in ER-positive breast cancer patients.